Roivant Sciences Stock (ROIV)
Track Roivant Sciences stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
ROIV
Roivant Sciences
healthcare
$35.40
▲ +18.18 (+113.41%) past year
Market Cap
$25.10B
P/E Ratio
—
1Y Return
+113.41%
EPS (TTM)
-$0.44
Read the latest TheStreet Pro articles mentioning Roivant Sciences, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
1 article
Daily Diary Mentions
0 mentionsNo diary mentions for ROIV yet.